Victory Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-235,949
| Closed | -$20.3M | – | 2658 |
|
|
2022
Q3 | $20.3M | Sell |
235,949
-41,061
| -15% | -$3.54M | 0.02% | 809 |
|
|
2022
Q2 | $22.9M | Buy |
277,010
+101,739
| +58% | +$8.41M | 0.03% | 772 |
|
|
2022
Q1 | $29.1M | Buy |
175,271
+139,651
| +392% | +$23.2M | 0.03% | 736 |
|
|
2021
Q4 | $5.96M | Sell |
35,620
-21,202
| -37% | -$3.55M | 0.01% | 1286 |
|
|
2021
Q3 | $4.91M | Buy |
56,822
+13,037
| +30% | +$1.13M | ﹤0.01% | 1334 |
|
|
2021
Q2 | $2.38M | Sell |
43,785
-2,690
| -6% | -$146K | ﹤0.01% | 1580 |
|
|
2021
Q1 | $2.77M | Sell |
46,475
-1,850
| -4% | -$110K | ﹤0.01% | 1544 |
|
|
2020
Q4 | $2.52M | Sell |
48,325
-8,524
| -15% | -$445K | ﹤0.01% | 1449 |
|
|
2020
Q3 | $2.75M | Sell |
56,849
-1,908
| -3% | -$92.4K | ﹤0.01% | 1349 |
|
|
2020
Q2 | $3.04M | Sell |
58,757
-215,248
| -79% | -$11.2M | ﹤0.01% | 1305 |
|
|
2020
Q1 | $11.9M | Buy |
274,005
+224,460
| +453% | +$9.79M | 0.01% | 1026 |
|
|
2019
Q4 | $1.99M | Buy |
49,545
+3,388
| +7% | +$136K | ﹤0.01% | 1511 |
|
|
2019
Q3 | $1.51M | Buy |
46,157
+12
| +0% | +$394 | ﹤0.01% | 1568 |
|
|
2019
Q2 | $3.56M | Buy |
46,145
+23,711
| +106% | +$1.83M | 0.01% | 991 |
|
|
2019
Q1 | $3.98M | Sell |
22,434
-235
| -1% | -$41.7K | 0.01% | 903 |
|
|
2018
Q4 | $5.35M | Sell |
22,669
-19,850
| -47% | -$4.68M | 0.01% | 813 |
|
|
2018
Q3 | $9.1M | Sell |
42,519
-2,348
| -5% | -$503K | 0.02% | 770 |
|
|
2018
Q2 | $7.76M | Buy |
+44,867
| New | +$7.76M | 0.02% | 793 |
|